Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toremifene and Goserelin in Premenopausal HR+ Breast Cancer
NCT02132390Phase 3Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2014
- Primary completion
- May 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin in breast cancer, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
goserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02132390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132390.